February 17, 2021Journal of Experimental & Clinical Cancer ResearchOpen Access

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

View Full Paper

Ask AI

Bookmark

Abstract

Our results demonstrate that miR-34a directly targets MET and maintains anti-tumor immune activity. We propose miR-34a as a potential new therapeutic approach for HNSCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2021) studied this question.

synapsesocial.com/papers/69d71af4523bf2ea07f507e3 https://doi.org/10.1186/s13046-021-01865-2

View Full Paper

Ask AI

Bookmark

Abstract

Our results demonstrate that miR-34a directly targets MET and maintains anti-tumor immune activity. We propose miR-34a as a potential new therapeutic approach for HNSCC.

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

Abstract

Discussion

Cite This Study

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

Abstract

Discussion

Cite This Study

Keep reading

Keep reading